England G C, Clarke K W, Goossens L
Department of Surgery and Obstetrics, Royal Veterinary College, University of London, Hatfield, Hertfordshire, UK.
J Vet Pharmacol Ther. 1992 Jun;15(2):194-201. doi: 10.1111/j.1365-2885.1992.tb01007.x.
The sedative effects of a new alpha 2-adrenoceptor agonist, romifidine, were compared with those of xylazine and detomidine. Five horses were treated with two doses of romifidine (40 micrograms/kg body weight and 80 micrograms/kg body weight), two doses of detomidine (10 micrograms/kg body weight and 20 micrograms/kg body weight) and one dose of xylazine (1 mg/kg body weight) given by intravenous injection using a Latin-square design. The dose of 80 micrograms/kg romifidine appeared equipotent to 1 mg/kg xylazine and 20 micrograms/kg detomidine, although at these doses both xylazine and detomidine had a shorter action. Detomidine 20 micrograms/kg and xylazine both produced greater lowering of the head and a greater degree of ataxia than romifidine at either dose. Romifidine produced sedation similar to that of the other drug regimes. The effect upon imposed stimuli was similar.
将一种新型α2-肾上腺素能受体激动剂罗米非定的镇静效果与赛拉嗪和地托咪定的镇静效果进行了比较。采用拉丁方设计,对5匹马静脉注射两剂罗米非定(40微克/千克体重和80微克/千克体重)、两剂地托咪定(10微克/千克体重和20微克/千克体重)和一剂赛拉嗪(1毫克/千克体重)。80微克/千克罗米非定的剂量似乎与1毫克/千克赛拉嗪和20微克/千克地托咪定等效,尽管在这些剂量下,赛拉嗪和地托咪定的作用时间较短。20微克/千克地托咪定和赛拉嗪在两种剂量下均比罗米非定更能使头部低垂,共济失调程度更高。罗米非定产生的镇静作用与其他用药方案相似。对施加刺激的效果也相似。